Sun Pharma enters patent litigation settlement with Celgene for launch of generic Revlimid

Intellectual Property, Litigation News

... subsidiary of Bristol Myers Squibb (BMS), to resolve the patent litigation regarding submission of an Abbreviated New Drug Application (ANDA) for a ...